down arrow

Everest Organics

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE334C01029
  • NSEID:
  • BSEID: 524790
INR
303.00
-9.85 (-3.15%)
BSENSE

Apr 11, 12:49 PM

BSE+NSE Vol: 2.08 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

287.15311.25

52 Week

112.50323.50
Valuation
Technical
Day's Volume

CASH

2.08 k (-83.13%) Volume

Shareholding (Mar 2025)

FII

0.00%

Held by 0 FIIs

DII

0.02%

Held by 0 DIIs

Promoter

61.09%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Weak Long Term Fundamental Strength with a -50.40% CAGR growth in Operating Profits over the last 5 years

  • Low ability to service debt as the company has a high Debt to EBITDA ratio of 6.02 times
2

Positive results in Dec 24

3

Stock is technically in a Bullish range

4

With ROCE of -0.6, it has a Very Expensive valuation with a 3.9 Enterprise value to Capital Employed

5

Majority shareholders : Promoters

 
6

Market Beating performance in long term as well as near term

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 299 Cr (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

1.25

stock-summary
Return on Equity

-10.22%

stock-summary
Price to Book

7.50

Revenue and Profits (1 Year):
Net Sales:
42 Cr
(Quarterly Results - Dec 2024)
Net Profit:
1 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
127.99%
0%
127.99%
1 Year
136.53%
0%
136.53%
2 Years
207.43%
0%
207.43%
3 Years
45.15%
0.31%
45.46%
4 Years
26.28%
0.44%
26.72%
5 Years
206.53%
3.12%
209.65%

Latest dividend: 0.5 per share ex-dividend date: Sep-15-2022

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
-0.21%
EBIT Growth (5y)
-50.40%
EBIT to Interest (avg)
1.58
Debt to EBITDA (avg)
14.75
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
2.10
Tax Ratio
2.73%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.02%
ROCE (avg)
3.41%
ROE (avg)
11.49%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
33
Price to Book Value
7.50
EV to EBIT
354.40
EV to EBITDA
52.43
EV to Capital Employed
3.89
EV to Sales
2.07
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-0.64%
ROE (Latest)
-10.22%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Veerat Finance Investment Limited (38.37%)

Highest Public shareholder

Greenpath Energy Private Limited (8.47%)

Individual Investors Holdings

23.87%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -4.54% vs 35.75% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 52.00% vs 112.32% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "42.05",
          "val2": "44.05",
          "chgp": "-4.54%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "4.02",
          "val2": "3.43",
          "chgp": "17.20%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.40",
          "val2": "1.35",
          "chgp": "3.70%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "1.14",
          "val2": "0.75",
          "chgp": "52.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "9.56%",
          "val2": "7.79%",
          "chgp": "1.77%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is -16.97% vs 3.51% in Sep 2023",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is -1,883.33% vs 116.48% in Sep 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "76.49",
          "val2": "92.12",
          "chgp": "-16.97%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.23",
          "val2": "5.23",
          "chgp": "-104.40%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "2.64",
          "val2": "2.78",
          "chgp": "-5.04%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-5.35",
          "val2": "0.30",
          "chgp": "-1,883.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-0.30%",
          "val2": "5.68%",
          "chgp": "-5.98%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -18.04% vs 9.33% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -1,415.62% vs 206.67% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "118.54",
          "val2": "144.63",
          "chgp": "-18.04%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "3.79",
          "val2": "8.03",
          "chgp": "-52.80%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "4.04",
          "val2": "4.23",
          "chgp": "-4.49%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-4.21",
          "val2": "0.32",
          "chgp": "-1,415.62%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "3.20%",
          "val2": "5.55%",
          "chgp": "-2.35%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 7.75% vs -8.50% in Mar 2023",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 177.78% vs -115.79% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "197.24",
          "val2": "183.05",
          "chgp": "7.75%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "10.99",
          "val2": "0.93",
          "chgp": "1,081.72%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "5.47",
          "val2": "3.31",
          "chgp": "65.26%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.14",
          "val2": "-0.18",
          "chgp": "177.78%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "5.57%",
          "val2": "0.51%",
          "chgp": "5.06%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Standalone) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
42.05
44.05
-4.54%
Operating Profit (PBDIT) excl Other Income
4.02
3.43
17.20%
Interest
1.40
1.35
3.70%
Exceptional Items
0.00
0.00
Standalone Net Profit
1.14
0.75
52.00%
Operating Profit Margin (Excl OI)
9.56%
7.79%
1.77%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is -4.54% vs 35.75% in Sep 2024

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Dec 2024 is 52.00% vs 112.32% in Sep 2024

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Standalone) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
76.49
92.12
-16.97%
Operating Profit (PBDIT) excl Other Income
-0.23
5.23
-104.40%
Interest
2.64
2.78
-5.04%
Exceptional Items
0.00
0.00
Standalone Net Profit
-5.35
0.30
-1,883.33%
Operating Profit Margin (Excl OI)
-0.30%
5.68%
-5.98%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is -16.97% vs 3.51% in Sep 2023

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2024 is -1,883.33% vs 116.48% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Standalone) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
118.54
144.63
-18.04%
Operating Profit (PBDIT) excl Other Income
3.79
8.03
-52.80%
Interest
4.04
4.23
-4.49%
Exceptional Items
0.00
0.00
Standalone Net Profit
-4.21
0.32
-1,415.62%
Operating Profit Margin (Excl OI)
3.20%
5.55%
-2.35%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is -18.04% vs 9.33% in Dec 2023

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Dec 2024 is -1,415.62% vs 206.67% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Standalone) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
197.24
183.05
7.75%
Operating Profit (PBDIT) excl Other Income
10.99
0.93
1,081.72%
Interest
5.47
3.31
65.26%
Exceptional Items
0.00
0.00
Standalone Net Profit
0.14
-0.18
177.78%
Operating Profit Margin (Excl OI)
5.57%
0.51%
5.06%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 7.75% vs -8.50% in Mar 2023

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2024 is 177.78% vs -115.79% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Everest Organics Ltd stock-summary
stock-summary
Everest Organics Ltd
Micro Cap
Pharmaceuticals & Drugs
Everest Organics Ltd was incorporated at Hyderabad in Feb.'93. It was promoted by S K Srihari Raju and S K Chittiramabhadra Raju. The Company is engaged in manufacturing of Active Pharmaceutical Ingredients and their intermediaries. The Company commenced its commercial operations in the year 1993. It set up a plant at Aroor, Andhra Pradesh to manufacture bulk drugs and formulations. It came out with a public issue in Jan.'95 to part-finance the project.
Company Coordinates stock-summary
Company Details
Aroor Village, Sadasivpet Mandal Medak Telangana : 502291
stock-summary
Tel: 91-8455-250113
stock-summary
http://www.everestorganicsltd.com
stock-summary
srihari_everest@rediffmail.com
Registrar Details
Venture Capital & Corporate Investments Ltd , 12-10-167,, MIG- 167,, Bharat Nagar Colony, Hyderabad
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."